<div id="readability-page-1">03:59 PM EDT, 05/11/2026 (MT Newswires) -- Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Healthcare Select Sector SPDR ETF (XLV) declining 0.4%.The iShares Biotechnology ETF (IBB) was little changed.In corporate news, Zoetis ( ZTS ) shares fell 7.5% after BNP Paribas cut its price target to $146 from $185, following the company's Q1 results late last week.Moderna ( MRNA ) has been working on early-stage vaccines targeting hantaviruses, Bloomberg reported Friday, citing a company statement. The research began before recent infections were reported aboard the Dutch-flagged Hondius, the report said. Moderna ( MRNA ) shares fell 3.7%.Sonida Senior Living ( SNDA ) shares fell 3.3% after the company reported Q1 loss of $2.39 per diluted share, widening from the loss of $0.77 a year earlier. Analysts polled by FactSet expected a loss of $1.53.Erasca ( ERAS ) entered into a clinical trial collaboration and supply agreement with Merck (MRK) to study its investigational drug ERAS-0015 in combination with Keytruda in patients with RAS-mutant solid tumors. Erasca ( ERAS ) shares rose 3%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MRNA

SNDA

ERAS

Healthcare stocks declined late Monday, with the NYSE Healthcare Index down 0.3% and the State Street Healthcare Select Sector SPDR ETF down 0.4%. Zoetis shares fell 7.5% after a price target cut by BNP Paribas. Moderna shares dropped 3.7% amid news of early-stage vaccine development. Sonida Senior Living reported a Q1 loss of $2.39 per share, leading to a 3.3% decline in shares. In contrast, Erasca shares rose 3% following a collaboration with Merck for a clinical trial.

Sector Update: Healthcare Stocks Softer Late Afternoon